Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

计划入组 60 人 · 首次发布于 2020 年 4 月 17 日

Factors That Affect Trust Between Physicians and Patients

计划入组 200 人 · 首次发布于 2023 年 11 月 9 日

UCF Deciding Brains

计划入组 400 人 · 首次发布于 2023 年 12 月 19 日

dulaglutide depot

Rett syndrome therapeutics(Melior Discovery/Rett Syndrome Research Trust)

Anti-CEA-MFEz

Mapi-Pharma Ltd.

Israel

RETT SYNDROME RESEARCH TRUST

United States

PATANJALI RESEARCH FOUNDATION TRUST

India

ICON Launches Comprehensive Patient-Centric Outcome Measures Solution for Clinical Trials

Obesity Trial Surge Driven by GLP-1 Receptor Agonists and Decentralized Technologies

Royal Free London Opens New Clinical Trials Offering Hope for Pancreatic Cancer Patients